首页 | 本学科首页   官方微博 | 高级检索  
检索        

组织病理学同行评议的GLP要求及关注点探讨
引用本文:吕建军,霍桂桃,林志,屈哲,杨艳伟,张頔,霍艳,耿兴超,王雪,李波.组织病理学同行评议的GLP要求及关注点探讨[J].中国药事,2018,32(4):485-493.
作者姓名:吕建军  霍桂桃  林志  屈哲  杨艳伟  张頔  霍艳  耿兴超  王雪  李波
作者单位:中国食品药品检定研究院国家药物安全评价监测中心、药物非临床安全评价研究北京市重点实验室, 北京 100176,中国食品药品检定研究院国家药物安全评价监测中心、药物非临床安全评价研究北京市重点实验室, 北京 100176,中国食品药品检定研究院国家药物安全评价监测中心、药物非临床安全评价研究北京市重点实验室, 北京 100176,中国食品药品检定研究院国家药物安全评价监测中心、药物非临床安全评价研究北京市重点实验室, 北京 100176,中国食品药品检定研究院国家药物安全评价监测中心、药物非临床安全评价研究北京市重点实验室, 北京 100176,中国食品药品检定研究院国家药物安全评价监测中心、药物非临床安全评价研究北京市重点实验室, 北京 100176,中国食品药品检定研究院国家药物安全评价监测中心、药物非临床安全评价研究北京市重点实验室, 北京 100176,中国食品药品检定研究院国家药物安全评价监测中心、药物非临床安全评价研究北京市重点实验室, 北京 100176,中国食品药品检定研究院国家药物安全评价监测中心、药物非临床安全评价研究北京市重点实验室, 北京 100176,中国食品药品检定研究院, 北京 100050
基金项目:十二五国家科技重大专项课题“符合中药特点的有毒中药安评关键技术”(编号2015ZX09501004-002);十二五国家科技重大专项课题“生物大分子药物特殊评价关键技术研究”(编号2015ZX09501007-004)
摘    要:目的:探讨组织病理学同行评议的GLP要求及关注点。方法:简要介绍药物非临床安全性评价领域组织病理学同行评议的指导原则、目的、GLP要求、GLP符合性要求、种类、地点、病理工作组、同行评议病理学家和专题病理学家的职责、动物数量的选择、建议归档文件、同行评议声明以及使用数字扫描全切片图像进行同行评议等内容。结果:组织病理学同行评议可核实并提高病理诊断和病理解释的准确性、一致性及完整性,提高病理报告的质量;同时,可作为毒性病理学家继续教育的重要组成部分。结论:本文探讨组织病理学同行评议的GLP要求及关注点,以期为我国药物非临床安全性评价领域更好地开展符合GLP的组织病理学同行评议提供一些参考。

关 键 词:良好实验室规范  毒性病理学  组织病理学  同行评议  指导原则  病理工作组
收稿时间:2016/11/19 0:00:00

Discussion on GLP Requirements and Considerations in Peer Review of Histopathology
Lv Jianjun,Huo Guitao,Lin Zhi,Qu Zhe,Yang Yanwei,Zhang Di,Huo Yan,Geng Xingchao,Wang Xue and Li Bo.Discussion on GLP Requirements and Considerations in Peer Review of Histopathology[J].Chinese Pharmaceutical Affairs,2018,32(4):485-493.
Authors:Lv Jianjun  Huo Guitao  Lin Zhi  Qu Zhe  Yang Yanwei  Zhang Di  Huo Yan  Geng Xingchao  Wang Xue and Li Bo
Institution:Beijing Key Laboratory for Safety Evaluation of Drugs, National Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, Beijing 100176, China,Beijing Key Laboratory for Safety Evaluation of Drugs, National Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, Beijing 100176, China,Beijing Key Laboratory for Safety Evaluation of Drugs, National Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, Beijing 100176, China,Beijing Key Laboratory for Safety Evaluation of Drugs, National Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, Beijing 100176, China,Beijing Key Laboratory for Safety Evaluation of Drugs, National Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, Beijing 100176, China,Beijing Key Laboratory for Safety Evaluation of Drugs, National Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, Beijing 100176, China,Beijing Key Laboratory for Safety Evaluation of Drugs, National Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, Beijing 100176, China,Beijing Key Laboratory for Safety Evaluation of Drugs, National Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, Beijing 100176, China,Beijing Key Laboratory for Safety Evaluation of Drugs, National Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, Beijing 100176, China and National Institutes for Food and Drug Control, Beijing 100050, China
Abstract:Objective: To discuss GLP requirements and considerations in peer review of histopathology. Methods: This paper gave a brief introduction to the good laboratory practice (GLP) requirements and considerations in peer review of histopathology in nonclinical safety evaluation of drugs, including guidelines for peer review, purpose of peer review, GLP requirements of peer review, GLP compliant requirements of peer review, types of peer review, site of peer review, pathology working groups (PWGs), responsibilities of peer review pathologists and study pathologists, animal numbers to be reviewed, documents suggested to be archived, peer review statement, as well as utilizing whole slide images (WSIs) for peer review. Results: Peer review of histopathology can verify and improve the accuracy, consistency and completeness of pathology diagnoses and interpretation, improve the quality of the pathology report and serve as an important source of continuing education of toxicologic pathologists. Conclusion: The GLP requirements and considerations for peer review of histopathology were discussed with the aim to provide some references for better complying with GLP peer review of histopathology in nonclinical safety evaluation of drugs in China.
Keywords:good laboratory practice  toxicologic pathology  histopathology  peer review  guidance  pathology working groups
点击此处可从《中国药事》浏览原始摘要信息
点击此处可从《中国药事》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号